Sponsor Quotes

Cardiologists and other health care providers are reminded every day of the importance and impact of the National Institutes of Health’s (NIH) support for scientific investigations. Medical research is our country’s best hope to discover new ways to prevent, diagnose, treat and develop cures for cardiovascular disease. It is through robust funding that we can not only revolutionize patient care and drive innovation, but also advance health equity. The American Heart Association is pleased to stand alongside other public health and research organizations to urge Congress to protect and boost federal support for the NIH and prioritize funding for NIH heart and stroke research.

Keith Churchwell, MD, FAHA
President-Elect, American Heart Association

“Thanks to the transformative research that is funded by NIH, there is real hope on the horizon for improving outcomes and even curing some forms of cancer and other devastating medical conditions. Innovative new treatments are emerging every day. NIH supports research that improves the health of our entire nation, creates jobs, boosts the economy and ensures that America remains a global leader in health innovation.”

John L. Cleveland, PhD
Center Director and Executive Vice President, Moffitt Cancer Center

Federal funding for cancer research helps save lives and leads to an improved quality of life for patients and their loved ones. Thanks to a bipartisan commitment to supporting this research over the past several years, the cancer community has made monumental progress towards conquering cancer. However, robust and sustained federal research funding must continue to ensure that our vision of preventing and curing cancer comes to fruition, and every patient has equitable access to high-quality care. We call on Congress to maintain its investment in the National Institutes of Health and National Cancer Institute to ensure continued progress against cancer.

Everett E. Vokes, MD, FASCO
Chair of the Board, Association for Clinical Oncology

Look in your medicine cabinet. Do you see a medication for treating a chronic illness or preventing disease? Chances are you can thank the NIH for that. Think about someone who has survived cancer. If not for the NIH, that person might not be with us. Or consider the future of a friend or family member with Alzheimer’s disease, a heart condition, or mental illness. Where will we find the treatments to alleviate their suffering?
The answer almost certainly involves the NIH.

Katrina Armstrong, MD
Chief Executive Officer and Dean, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons

Thanks to longstanding bipartisan support in Congress, the NIH has been able to empower scientists to explore new pathways in Alzheimer’s and dementia research. This year, we saw the first FDA traditional approval of an Alzheimer’s treatment that changes the underlying course of the disease for those living with early Alzheimer’s. With continued support for medical research, our nation will drive scientific advances that could one day yield promising discoveries that benefit all those with dementia at any stage.

Rachel Conant
Vice President of Federal Affairs, Alzheimer’s Association

AACI represents over 100 leading academic cancer centers that are working to accelerate progress against cancer. To drive this progress, AACI members require stable, predictable increases in funding for the National Institutes of Health and the National Cancer Institute.

Jennifer W. Pegher
Executive Director, Association of American Cancer Institutes

Congress’ consistent investment in NIH and biomedical research has helped make cutting-edge treatments like CAR-T and gene therapies a reality. The research community is on the verge of more landmark treatments for life-threatening hematologic diseases, including blood cancers and sickle cell disease, and NIH funding is critical to that mission.

Robert A. Brodsky, MD
President, American Society of Hematology (ASH)

Biomedical research is how we uncover scientific knowledge that has led to and leads to discoveries that are essential for the understanding of diseases, their prevention, treatment and overall improving the health of all people. A robust and well-resourced biomedical research enterprise is foundational and essential to advancing public health.

Namandjé Bumpus, PhD
President, American Society for Pharmacology and Experimental Therapeutics (ASPET)

“As we have witnessed during this public health emergency, sustained and increased funding for biomedical and behavioral research is critical to supporting scientific discoveries that promote better health and wellness. The National Institute of Nursing Research is on the frontlines of this work. We thank our nurse scientists who are advancing evidence-based interventions and leading translational research that addresses health equity, social determinants of health, population health, and health promotion.

Deborah Trautman, PhD, RN, FAAN
President and Chief Executive Officer, American Association of Colleges of Nursing

“NIH’s investment in biomedical research is crucial to our nation’s capacity to respond to public health crises. The recent emergence of novel infectious diseases such as Covid-19 and Monkeypox emphasizes the critical need for advancements in clinical research and support for the scientific community. This funding further enables the development and advancement of cutting-edge treatments for life-threatening hematologic diseases, including blood cancers and sickle cell disease.”

Jane N. Winter, MD
President, Federal Affairs, American Society of Hematology

“Federal funding for human genetics and genomics research is enabling new insights into the structure of, and variation in, the human genome and leading to new discoveries in understanding, preventing, and treating disease. Genomic science can improve human health and advance health equity through the deliberate, meaningful inclusion and participation of individuals from diverse groups in research. Sustained funding increases for NIH are critical to ASHG’s mission that people everywhere realize the benefits of human genetics and genomics research.”

Brendan Lee, MD, PhD
President-Elect, American Society of Human Genetics

“A bipartisan commitment to robust funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI) is key to progress. Stable, predictable funding increases for the NIH and NCI accelerate lifesaving discoveries and support high quality care at AACI’s 105 member cancer centers.”

David J. Skorton, MD
President and Chief Executive Officer, Association of American Medical Colleges

“The groundbreaking medical research supported by the NIH nationwide generates medical discoveries that change the lives of patients, families, and communities everywhere. More than 50% of NIH-funded research takes place at the nation’s medical schools and teaching hospitals, leading to lifesaving vaccines and therapeutics, cures for diseases, and improved patient care. We are proud of the role that NIH and academic medicine play in helping Americans live longer, healthier lives.”

Jennifer W. Pegher
Executive Director, Association of American Cancer Institutes

“Thanks to historic Alzheimer’s and dementia research funding increases, scientists are able to work at a more rapid pace to advance the understanding of the disease, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and develop potential treatments. This investment directly empowers researchers to explore new pathways that could yield promising discoveries for the more than 6 million Americans living with Alzheimer’s. At any given moment, discovery is happening.”

Rachel Conant
Vice President, Alzheimer’s Association

“We are so thankful for the continued Congressional support and commitment to cancer research funding. Federal funding for biomedical and cancer research from the NIH and the NCI is vital to our work at Dana-Farber to advance the science, care, and prevention of cancer for all patients. These investments can lead to transformative discoveries that can save lives. I am proud to once again join my colleagues from across the country as we come together to call on Congress to make funding at the NIH a national priority.”

Laurie H. Glimcher, MD
President and Chief Executive Officer, Dana-Farber Cancer Institute

“Research support provided by the NIH is foundational to America’s biomedical enterprise.  As the largest public funder of biomedical research worldwide, the NIH is helping people live longer, making diseases less deadly, and developing an array of preventions and treatments. NIH efforts expand knowledge through basic research that industry can further develop and cultivates the biomedical workforce from early career researchers to academic faculty.”

Kevin C. Kregel, PhD
President, Federation of American Societies for Experimental Biology (FASEB)

“A sustained robust investment in evidence-based research and data collection programs at NIH is critical to addressing our nation’s maternal and infant health crisis. These critical investments assist in speeding the development of life-saving treatments for moms and babies. March of Dimes is a proud partner on the ‘Rally for Medical Research Hill Day’ and we look forward to meeting with bipartisan Members of Congress to discuss the importance of maintaining a strong commitment to research to meet current and future public health challenges.”

Stacey Y. Brayboy
Senior Vice President, March of Dimes 

“Childhood cancer research uniquely depends on the federal government as its primary source of funding. Thanks to greater awareness and advocacy, the National Cancer Institute has more than doubled its investment in childhood cancer research in recent years. Despite these needed resources, 1 in 5 children diagnosed with cancer in the United States will not survive. The St. Baldrick’s Foundation is proud to join with the research community to urge Congress to provide additional increases for the National Institutes of Health to fund life-saving research and to develop new, safer therapies for kids with cancer.”

Kathleen Ruddy
Chief Executive Officer, St. Baldrick’s Foundation
“Thanks to NIH-funded research, advances in cancer care have moved at a phenomenal pace over the last several years. Today, more people are surviving cancer than ever before. Sustained and predictable funding helps us keep this momentum, leading to more breakthrough discoveries, cures and lives saved.”

Roy Jensen, MD
Vice Chancellor and Director, The University of Kansas Cancer Center
“Sustained NIH funding and increased funding for new initiatives drive discoveries in oncology and in many other areas vital to our heath. By continuing to apply our knowledge of cancer biology, bioinformatics, viral oncology and population science, we can positively influence the health of our nation. Our recent experiences with the COVID 19 pandemic have shown that funding is critical in sustaining the health and safety of our population, including racial and ethnic minority communities, rural communities and underserved communities.”

Alan E. Tomkinson, PhD
Vice Chancellor and Director, The University of New Mexico Comprehensive Cancer Center